Unknown OBSERVATIONAL NCT06103123

MYocarditis and/or Pericarditis Following mRNA COVID-19 VACCination National Surveillance Study (MYCOVACC)

Sponsor: Cardiology Research UBC

Conditions Myocarditis Myocarditis Acute Pericarditis Pericarditis Acute

Interventions Baseline Quality of Life questionnaire Stand of care ECG, Holter, MRI, ECHO, Quality of life questionnaire

Updated 4 times since 2023 Last updated: Oct 24, 2023 Started: Apr 23, 2023 Primary completion: Mar 23, 2025 Completion: Apr 23, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Myocarditis and Myocarditis Acute, this trial is ongoing. The trial is conducted by Cardiology Research UBC and has accumulated 4 data snapshots since 2023. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

4 versions recorded

Dec 2025 — Present [monthly]

Unknown

Status: Recruiting → Unknown
Sep 2024 — Dec 2025 [monthly]

Recruiting
Jul 2024 — Sep 2024 [monthly]

Recruiting
Nov 2023 — Jul 2024 [monthly]

Recruiting

First recorded

Apr 2023

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Cardiology Research UBC

Data source: Cardiology Research UBC

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Vancouver, Canada